|
Delayed
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 19.90 USD | +0.25% |
|
-4.51% | +28.97% |
| 09-04 | Climb Bio's Phase-1 Data From IgA Nephropathy Trial 'Positive,' Wedbush Says | MT |
| 08-10 | Wedbush Adjusts Price Target on Jade Biosciences to $47 From $45, Keeps Outperform Rating | MT |
Chart calendar Jade Biosciences, Inc.
Upcoming events on Jade Biosciences, Inc.
No events available
Past events on Jade Biosciences, Inc.
| 2026-06-09 | Présentation aux Actionnaires / Analystes | 17:30 |
| 2026-06-08 | Annual General Meeting | |
| 2026-06-01 | Information meeting | 08:00 |
| 2025-10-07 | Information meeting | 08:00 |
Annual results
| Fiscal Period | December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -224 | -232 | -240 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -114 -103 -9.72% | -213 | -237 | -262 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -127 -120 -5.86% | -206 | -235 | -259 |
|
Net income Million USD | Released Forecast Spread | -69,6 | -127 -115 -11.26% | -204 | -231 | -259 |
|
EPS USD | Released Forecast Spread | -2,44 | -3,19 -2,95 -7.98% | -2,92 | -2,87 | -2,84 |
| Announcement Date | 25/03/25 | 06/03/26 | - |
Quarterly results
| Fiscal Period | June | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -23,4 -13,0 -79.88% | -27,8 -19,5 -42.45% | -27,4 -26,0 -5.55% | -35,0 -28,3 -23.47% | -43,4 -34,9 -24.51% | -58,9 -43,7 -34.75% | -54,5 | -55,6 | -57,3 | -59,3 | -61,5 | -63,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -38,2 -13,0 -193.61% | -32,1 -20,3 -58.04% | -25,2 -26,2 3.85% | -31,9 -27,9 -14.43% | -40,4 -32,5 -24.14% | -55,8 -42,3 -31.82% | -53,4 | -55,1 | -57,5 | -60,1 | -62,9 | -66,0 |
|
Net income Million USD | Released Forecast Spread | -38,2 -13,0 -193.61% | -32,1 -20,3 -58.04% | -25,2 -27,5 8.4% | -31,9 -27,5 -16% | -40,4 -32,5 -24.12% | -55,8 -42,2 -32.26% | -52,4 | -54,0 | -54,0 | -56,2 | -58,5 | -61,1 |
|
EPS USD | Released Forecast Spread | -12,1 -2,05 -490.24% | -0,86 -0,48 -79.17% | -0,48 -0,67 28.36% | -0,47 | -0,57 -0,48 -19.37% | -0,76 -0,63 -20.18% | -0,73 | -0,75 | -0,74 | -0,77 | -0,76 | -0,79 |
| Announcement Date | 14/05/25 | 13/08/25 | 13/11/25 | 06/03/26 | 07/05/26 | 10/08/26 | - | - | - | - | - | - |
| 2026-09-07 |  | Earnings presentation | 21:00 |
| 2026-09-07 | | Annual General Meeting | |
| 2026-09-08 | | Information meeting | 07:00 |
| 2026-09-08 | | Extraordinary General Meeting | 11:00 |
| 2026-09-08 | | Information meeting | 08:00 |
| 2026-09-08 | | Présentation aux Actionnaires / Analystes | 17:00 |
| 2026-09-09 | | Earnings presentation | 04:30 |
| 2026-09-09 | | Extraordinary General Meeting | 22:00 |
| 2026-09-09 | | Information meeting | 10:00 |
| 2026-09-10 | | Extraordinary General Meeting | 02:30 |
Past sector events for Jade Biosciences, Inc.
| Today | | Significant Split/Dividend | 00:00 |
| 2026-09-04 | | Information meeting | 10:00 |
| 2026-09-03 | | Information meeting | 20:01 |
| 2026-09-02 | | Annual General Meeting | 13:00 |
| 2026-09-02 | | Présentation aux Actionnaires / Analystes | 13:00 |
| 2026-09-02 | | Présentation aux Actionnaires / Analystes | |
| 2026-09-01 | | Information meeting | 13:00 |
| 2026-08-31 | | Information meeting | 08:30 |
| 2026-08-30 | | Board of Directors Meeting | |
| 2026-08-30 | | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- JBIO Stock
- Calendar Jade Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
